RXRX vs BBAI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

RXRX

53.9
AI Score
VS
BBAI Wins

BBAI

56.6
AI Score

Investment Advisor Scores

RXRX

54score
Recommendation
HOLD

BBAI

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RXRX BBAI Winner
Revenue 6.47M 71.18M BBAI
Net Income -117.50M -82.51M BBAI
Net Margin -1815.6% -115.9% BBAI
Operating Income -128.50M -52.81M BBAI
ROE -11.5% -10.7% BBAI
ROA -8.8% -9.8% RXRX
Total Assets 1.34B 841.31M RXRX
Cash 654.47M 36.28M RXRX
Current Ratio 5.47 5.67 BBAI
Free Cash Flow -81.36M -40.84M BBAI

Relative Price Performance (Last 90 Days)

RXRX 1M: -16.7% · 3M: -6.6% BBAI 1M: -18.8% · 3M: -30.8%

Current Technical Phase

RXRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.0 · Price: $3.17

BBAI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.7%), weak momentum, RSI 41

RSI (14): 40.5 · Price: $2.87

Fundamentals Snapshot

Metric RXRX BBAI
Market Cap
Forward P/E -3.2 -18.6
Trailing P/E
Revenue (TTM)
Revenue Growth -0.6% 0.0%
Gross Margin -6.5% 0.3%
Operating Margin -19.9% -0.7%
EPS -1.12 -0.75
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBAI is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.